Ligand profile
ZINC136782209
Virtual-screening candidate from ZINC.
Bound to: VK055_4511 — ribonucleoside-diphosphate reductase, alpha subunit
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC136782209- UniProt (similar protein)
P23921- Tanimoto
- 0.667
- Target protein
- VK055_4511
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 113.7
- −1 ≤ LogP ≤ 5 -0.91
- MW ≤ 500 Da 305.2
- LogP ≤ 5 -0.91
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 113.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1CC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
InChI=1S/C11H13F2N3O5/c1-5(18)14-7-2-3-16(10(20)15-7)9-11(12,13)8(19)6(4-17)21-9/h2-3,6,8-9,17,19H,4H2,1H3,(H,14,15,18,20)/t6-,8-,9-/m1/s1InChI=1S/C11H13F2N3O5/c1-5(18)14-7-2-3-16(10(20)15-7)9-11(12,13)8(19)6(4-17)21-9/h2-3,6,8-9,17,19H,4H2,1H3,(H,14,15,18,20)/t6-,8-,9-/m1/s1
ANAFZSZOZIXNFX-FTLITQJKSA-NANAFZSZOZIXNFX-FTLITQJKSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- GEO
- Homolog
- P23921
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC136782209 →
- ZINC ZINC20 ZINC136782209 →
- UniProt UniProt P23921 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC136782209”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4511.
PDB 14
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 9
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).